The result is a number read against thresholds printed on the laboratory report. A clinician reads that number alongside genetic testing and the clinical picture and decides what it reflects. Nothing on a single report settles the question by itself.
It measures the concentration of chloride in sweat that has been deliberately stimulated from a small, cleaned area of skin, reported in the units printed on the laboratory report.
To understand why that number carries information, it helps to look at how a sweat gland works. The gland has two parts. A coiled section deep in the skin produces a primary fluid that is about as salty as the fluid around your cells. That fluid then travels up a narrow duct toward the surface. The duct lining is built to claw salt back before the sweat reaches the skin, pulling chloride out of the fluid and letting water stay behind. The protein that does the chloride part of that job is the cystic fibrosis transmembrane conductance regulator, or CFTR, a channel sitting in the duct wall.
When CFTR works well, sweat arrives at the skin surface with much of its chloride stripped out. When the CFTR protein is absent, misfolded or poorly functioning, the duct cannot reabsorb chloride efficiently, and the sweat that reaches the surface stays salty. The test does not read genes and does not look at lungs or pancreas. It reads the functional consequence of CFTR activity in one accessible tissue, which is what makes it so useful.
That functional angle also explains a limitation. The number reflects how well chloride moved through sweat duct membranes on the day of collection, under the conditions of that collection. Technique, sample size and skin condition all feed into it, which is why laboratories follow standardised collection and measurement methods and why consensus guidance treats methodology as part of the result itself 1.
Sweat is the only place where CFTR function can be sampled directly, without a needle, a scope or a scan, in a baby a few weeks old.
CFTR sits in the lining of the airways, the pancreatic ducts, the bile ducts, the intestine, the vas deferens and the sweat duct. In the organs that cause the clinical burden of cystic fibrosis, poor chloride movement leads to thick, sticky secretions that obstruct and inflame. Those organs are hard to sample and their problems take time to appear. The sweat duct is different. It is millimetres from the surface, it can be switched on chemically, and its output can be collected and sent to a laboratory.
The salty skin of affected children was described by families long before anyone knew what CFTR was, and that observation is what the modern test formalises. Consensus guidelines from the Cystic Fibrosis Foundation place sweat chloride measurement at the centre of the diagnostic pathway, with genetic analysis and clinical assessment built around it 1. Guidance covering the diagnosis and management of cystic fibrosis, including NICE guideline 78, sets out the same structure of sweat testing alongside genetic testing and specialist assessment 3.
There is also a practical reason. Cystic fibrosis is caused by variants in a single gene, but hundreds of variants exist and gene panels do not carry all of them. A functional readout from sweat captures the effect of variants a panel may not list.
Referrals come from three directions: a positive newborn screen, a clinical picture that raises the question, and a family history.
Newborn screening programmes are the largest source. A screening programme flags infants whose blood spot result crosses the programme cut-off, and those infants are referred for sweat testing as the next step 6. A flagged screen is a signal to test further, not a conclusion about the baby.
The clinical route applies when features of cystic fibrosis appear without a screening flag, or in people born before screening programmes existed. Features that can prompt a referral include poor weight gain despite a good appetite, greasy or bulky stools, a persistent wet cough, repeated chest infections, nasal polyps, salty tasting skin, and bowel obstruction at birth. None of these features belongs to cystic fibrosis alone, which is the point of testing rather than guessing.
Family history is the third route. A sibling or close relative with a confirmed diagnosis changes the pre-test picture enough that clinicians test even when a child looks well.
Adults are referred too. Studies suggest that a diagnosis made in adulthood can follow milder or single-organ presentations, such as bronchiectasis, chronic sinus disease, recurrent pancreatitis or male infertility 2.
Sweat is stimulated chemically on a small patch of skin, collected into a sealed collector, and sent to the laboratory, which measures chloride concentration in the sample.
The sequence runs like this. A small area of skin on a limb is cleaned. A pad or gel containing a sweat stimulating medicine is placed on the skin, and a weak electrical current is applied to carry that medicine into the superficial skin, a step called iontophoresis. The current is low and the electrodes are removed once the stimulation step is finished. The area is cleaned again, and a sealed collector, either a coiled tube or an absorbent pad covered to stop evaporation, is strapped over the stimulated patch. Sweat produced by the stimulated glands collects there. The collector is then removed, sealed and sent to the laboratory, where the chloride concentration is measured and reported with the thresholds the laboratory uses.
Two details matter more than people expect. First, the laboratory needs a minimum amount of sweat before it will report a number, because a very small sample can be distorted by evaporation or contamination. Second, many centres collect from two separate sites so the result does not rest on a single collection. Consensus guidance treats both the collection method and the analytical method as part of a valid result rather than background detail 1.
Ask the testing centre to walk you through each step before the appointment. Centres do this test constantly and will explain what happens at each stage and what the child will feel.
Preparation is set by the testing centre, and the specific instructions come from your child's pediatrician or the centre itself rather than from a general guide.
A few things are worth raising before the appointment. Tell the centre about any skin condition, eczema, rash or broken skin on the arms or legs, because the collection site has to be intact. Ask whether creams, lotions, oils or barrier products should be kept off the skin beforehand. Tell the team about any medicines the child takes, including anything applied to the skin, and ask your prescriber whether any of them is worth mentioning to the laboratory. Mention recent illness, vomiting or poor feeding, because a child who is unwell or poorly hydrated may be asked to come back.
Centres also set a minimum age and body size before an infant can be tested, because very small or very young babies may not produce enough sweat for a reportable sample, and consensus guidance addresses when testing can proceed in newborns 1. If your baby is below the centre's threshold, the appointment gets rescheduled rather than cancelled.
Practical points help. Feeding can continue as the centre allows, a familiar blanket or toy can come along, and a second adult makes the collection stage easier. Ask the centre what the child will feel during stimulation, and tell the staff immediately if the child seems distressed at the site.
Results fall into three bands, and consensus guidelines from the Cystic Fibrosis Foundation define where the thresholds between them sit 1.
| Where the result falls | What laboratories regard it as | What can follow |
|---|---|---|
| Below the lower threshold printed on the report | Cystic fibrosis unlikely on the basis of this test alone | Clinician reviews the full picture, with further testing if features continue |
| Between the lower and upper thresholds, the intermediate band | Neither ruled in nor ruled out | Repeat sweat collection, extended CFTR gene analysis, specialist assessment |
| At or above the upper threshold | In the range the guidelines regard as consistent with cystic fibrosis | Referral to a specialist centre, genetic testing, clinician decides what it reflects |
The thresholds themselves appear as printed on your lab report. They can differ by laboratory, by the analytical method used, and by the person's age, and consensus guidance sets out separate interpretation for young infants 1. That is why reading a number off a report without its own printed thresholds beside it is not a safe exercise.
The useful framing is observation, then meaning, then next step. The observation is a chloride concentration. The meaning is a probability shift, not a verdict. The next step is a conversation with the clinician who ordered the test, who reads it against genetic results, symptoms and family history and decides what it reflects. A value outside the printed range is worth discussing with a clinician promptly.
An intermediate result leads to more testing rather than to a conclusion, and consensus guidance sets out that pathway explicitly 1.
Three things sit in that pathway: repeat sweat collection on a separate day, extended analysis of the CFTR gene beyond a basic variant panel, and assessment at a specialist centre. Some centres can also perform specialised physiological tests of CFTR function in the nose or the gut, which are done in a small number of laboratories.
In infants picked up by newborn screening whose sweat and genetic results do not resolve the question, consensus guidance defines a designation for that in-between state, described as CFTR-related metabolic syndrome or as CF screen positive, inconclusive diagnosis, with structured follow-up over time rather than a label applied on day one 1. Those children are followed at a centre, because the picture can clarify as they grow.
For families, the hardest part of an intermediate result is the uncertainty, not the number. It is reasonable to ask the centre what specific question each follow-up test is meant to answer, when the next step is scheduled, and what would change the plan. Write the answers down. Uncertainty handled with a timetable feels different from uncertainty handled without one.
A sweat test can fail to produce a usable result for technical reasons that have nothing to do with whether cystic fibrosis is present.
The list includes the following:
There is also a biological caveat. A small number of other conditions can raise sweat chloride without cystic fibrosis being present, and consensus guidance builds that into how results are read rather than treating the number in isolation 1. This is the single clearest argument against self-interpreting a report. A repeat test is not a sign that something went wrong with your child. It is a sign that the laboratory holds itself to a standard before reporting a number this consequential.
Newborn screening does not diagnose cystic fibrosis. It identifies infants who need a sweat test.
Screening programmes start from a dried blood spot taken in the first days of life. That spot is analysed for a pancreatic marker that can be elevated in newborns with cystic fibrosis, and many programmes add genetic analysis to the same sample before deciding whom to refer onward for sweat testing 6. A blood spot result above the programme cut-off means the next test is due, nothing more. Plenty of infants referred after a positive screen are later found not to have cystic fibrosis, which is the expected behaviour of a screening test designed to miss as few affected babies as possible.
The reason programmes exist at all is timing. Research suggests that earlier diagnosis through newborn screening may support lung function in early childhood compared with diagnosis made later on symptoms 4. Early identification also connects families to specialist nutrition and respiratory care before problems have accumulated.
Access is not uniform across the world. Research suggests that limited access to standardised sweat testing is associated with delayed diagnosis in low- and middle-income countries, where screening programmes and trained laboratories may not be in place 5. Where a programme does not exist, the clinical route becomes the main route, and a clinician has to raise the question from symptoms.
If a screening letter arrives, contact the centre named on it and book the sweat test. Do not wait to see whether symptoms appear.
Yes. Sweat testing is used in adults, and the principle is identical.
Adult referrals come from a different direction. Instead of a screening flag, the trigger is a clinical pattern that has not been explained: bronchiectasis without a clear cause, chronic sinus disease with polyps, recurrent pancreatitis, or male infertility linked to absent vas deferens. Studies suggest that cystic fibrosis diagnosed in adulthood can present in milder or single-organ forms rather than the full childhood picture 2.
That matters for interpretation. Adults whose CFTR function is partially preserved can produce results in the intermediate band rather than clearly above the upper threshold, and the clinician reads those results together with extended genetic analysis and the clinical history before deciding what they reflect 2. A number that would be straightforward in an infant can need more work in an adult.
For an adult who has carried unexplained respiratory or digestive symptoms for years, the practical step is to ask a clinician whether sweat testing belongs in the work-up and which centre performs it. Adult sweat testing is done at accredited laboratories, and a general clinic will not have the equipment on site.
Care moves to a specialist centre, where the diagnosis is assembled from the sweat result, genetic analysis and a full clinical assessment.
Guidance covering diagnosis and management, including NICE guideline 78, describes care delivered through specialist centres with a multidisciplinary team rather than through a single clinician 3. The early assessment looks at nutrition and growth, pancreatic function, respiratory status and airway cultures, and builds a follow-up schedule. Genetic analysis identifies which CFTR variants are present, which matters for family counselling and for the clinician's decisions about what comes next.
Families are offered genetic counselling, and siblings may be tested.
On therapy, one line covers it: treatment decisions belong to a licensed provider who has reviewed the person in front of them. Medicines, nutritional support and airway care are prescribed and adjusted by the specialist team, and a licensed provider evaluates whether any specific option is appropriate. Nothing on a webpage substitutes for that.
They are different measurements of different fluids and they answer different questions. A routine blood panel reports electrolytes circulating in blood, which reflect hydration, kidney handling and acid-base balance at the moment of the draw. A sweat chloride test reports the salt content of stimulated sweat, which reflects how one channel moves chloride through a sweat duct. A blood panel cannot stand in for a sweat test, and a sweat test says nothing about blood electrolytes.
What each number means, how it is run and how to read a value against the thresholds on your own report is covered on the Sodium page. Blood electrolytes are read as printed on your lab report, and a value outside that printed range is worth discussing with a clinician.
Sweat chloride is one input. Clinicians build the picture from several tests, and the specific set depends on age and presentation.
Blood markers of inflammation and nutrition appear on panels in this context as well, and they are read in words and in trend rather than as a single reading. FitScript tests 150+ biomarkers per year and Atlas, its AI health advisor, interprets those results, though sweat testing itself is performed by accredited laboratories attached to specialist services and sits outside a general biomarker panel.
Any result that falls outside the thresholds printed on the report is worth discussing with a clinician promptly, and a positive newborn screening letter means booking the sweat test the letter directs you to.
Call 911 or go to the emergency department for any of these:
Contact your clinician, or your child's pediatrician, promptly for any of these:
Bring the printed report to the appointment, including the thresholds the laboratory lists beside the value. This article is educational and is not medical advice. Discuss your results, your child's results and any treatment with a clinician or licensed provider who can review the whole picture.
Related reading on FitScript: what causes high chloride explains the chloride that appears on a routine blood panel, which is a different measurement from sweat chloride, and night sweats before period covers a separate sweating question.
No. A newborn screening result that crosses the programme cut-off identifies babies who need a sweat test next, and many of those babies turn out not to have cystic fibrosis. The sweat test, genetic analysis and a clinician's assessment together decide what the picture reflects. Book the appointment the screening letter directs you to rather than waiting for symptoms.
A small area of skin on an arm or leg is cleaned, a pad containing a sweat stimulating medicine is applied, and a weak electrical current helps carry it into the surface of the skin. The pad and electrodes are then removed and a sealed collector is strapped over the spot to gather sweat. The collector goes to the laboratory, which measures the chloride concentration and reports it with its own thresholds.
Ask the testing centre what your child will feel at each stage, because they perform this test every day and can describe it precisely. Tell the staff straight away if your child seems distressed at the collection site. Bringing a second adult and something familiar for the child makes the collection stage easier to manage.
No number is reported and the collection is repeated. Laboratories set a minimum sample size because a very small sample can be distorted by evaporation or contamination, and a result that cannot be trusted is worse than no result. A repeat appointment is a quality step, not a sign that something has gone wrong with your child.
It means the question is not settled either way, so more testing follows. That can include a repeat sweat collection on a different day, extended analysis of the CFTR gene, and assessment at a specialist centre. Ask the centre what each follow-up test is meant to answer and when it is scheduled, and write the answers down.
A value below the lower threshold printed on the report makes cystic fibrosis unlikely on the basis of that test, but a clinician reads it alongside symptoms, family history and any genetic results before deciding. If features that prompted the referral continue, say so at the follow-up appointment rather than assuming the question is closed. The clinician decides whether further testing is warranted.
Yes, and the method is the same. Adults are referred when an unexplained pattern such as bronchiectasis, chronic sinus disease with polyps, recurrent pancreatitis or male infertility raises the question. Ask a clinician whether sweat testing belongs in the work-up and which accredited laboratory in your area performs it, since general clinics do not have the equipment on site.
No. A blood panel reports electrolytes circulating in blood, which reflect hydration, kidney handling and acid-base balance at the moment of the draw. A sweat chloride test reports the salt content of stimulated sweat and reflects how one channel moves chloride through a sweat duct. One cannot substitute for the other, and each is read against the thresholds printed on its own report.